Efficacy of JAK-inhibition in therapy-refractory full-house membranous glomerulopathy with type I interferon-pathway activation in the setting of anti-synthetase syndrome: a case report

Heliyon · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles